Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack N Barnes

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|September 3, 2005
A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic massesWhitney A Spannuth, Rodney P Rocconi, Warner K Huh, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 22, 2008
Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumorsRodney P Rocconi, Kellie S Matthews, Kristopher J Kimball, et al.
The Journal of Reproductive Medicine|March 17, 2004
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case seriesCharles A Leath, J Michael Straughn, Michael G Conner, et al.
Journal of the American College of Surgeons|September 27, 2006
Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapyJacob M Estes, Charles A Leath, J Michael Straughn, et al.
Gynecologic Oncology|July 5, 2005
Feasibility of performing chemoprevention trials in women at elevated risk of ovarian carcinoma: initial examination of celecoxib as a chemopreventive agentMack N Barnes, David F Chhieng, Mackenzie Dreher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2013
Perioperative morbidity and mortality in octogenarians with ovarian cancerChristen L Walters, Kellie E Schneider, Jenny M Whitworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agentsCristina Rodríguez-Burford, Mack N Barnes, Denise K Oelschlager, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinomaJanelle M Fauci, Kellie E Schneider, Peter J Frederick, et al.
Gynecologic Oncology|January 22, 2005
Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene deliveryMinghui Wang, Akseli Hemminki, Gene P Siegal, et al.
Gynecologic Oncology|November 15, 2011
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group studyDavid H Moore, Shamshad Ali, Wui-Jin Koh, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|September 3, 2005
A comparison of hand-assisted laparoscopy and conventional laparotomy for the surgical evaluation of pelvic massesWhitney A Spannuth, Rodney P Rocconi, Warner K Huh, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|May 22, 2008
Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumorsRodney P Rocconi, Kellie S Matthews, Kristopher J Kimball, et al.
The Journal of Reproductive Medicine|March 17, 2004
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case seriesCharles A Leath, J Michael Straughn, Michael G Conner, et al.
Journal of the American College of Surgeons|September 27, 2006
Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapyJacob M Estes, Charles A Leath, J Michael Straughn, et al.
Gynecologic Oncology|July 5, 2005
Feasibility of performing chemoprevention trials in women at elevated risk of ovarian carcinoma: initial examination of celecoxib as a chemopreventive agentMack N Barnes, David F Chhieng, Mackenzie Dreher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2013
Perioperative morbidity and mortality in octogenarians with ovarian cancerChristen L Walters, Kellie E Schneider, Jenny M Whitworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agentsCristina Rodríguez-Burford, Mack N Barnes, Denise K Oelschlager, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinomaJanelle M Fauci, Kellie E Schneider, Peter J Frederick, et al.
Gynecologic Oncology|January 22, 2005
Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene deliveryMinghui Wang, Akseli Hemminki, Gene P Siegal, et al.
Gynecologic Oncology|November 15, 2011
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group studyDavid H Moore, Shamshad Ali, Wui-Jin Koh, et al.
Pageof 5